FDA Warns Amazon and Walmart Over Unapproved Herpes Treatments, Citing Public Health Risks

Introduction

The U.S. Food and Drug Administration (FDA) has taken decisive action against major online retailers Amazon and Walmart, issuing warning letters over the sale of numerous unapproved products marketed as treatments for genital herpes. The agency asserts that these items, readily available to consumers, pose a significant public health risk by potentially misleading individuals into believing they are receiving effective treatment, thereby delaying crucial medical diagnosis and care from licensed healthcare professionals.

Key Details

• The FDA sent warning letters to Amazon and Walmart on October 1, 2026, concerning unapproved drugs sold on their platforms.
• Agency staff purchased nine products from Amazon and three from Walmart in July 2026, all marketed for herpes relief.
• These products, including FemiClear, HClear for him, HerpCare Ointment, Herstat GST, and Terragen HG Formula, claim to fight outbreaks, reduce flare-ups, and soothe sores.
• Several products are marketed as homeopathic, but the FDA emphasizes they are still subject to the same drug approval regulations.
• The FDA highlighted that these items are unapproved drugs and cannot legally be shipped across state lines.
• Amazon and Walmart are involved because they stored and shipped these products through their fulfillment programs, despite being sold by third-party sellers.
• Both companies have 15 business days to respond to the FDA with corrective actions, or face potential product seizure or legal action.

Background

Genital herpes, caused by the herpes simplex virus, is a common sexually transmitted infection in the United States. According to the Centers for Disease Control and Prevention (CDC), an estimated 572,000 new infections occurred in 2018 among individuals aged 14 to 49. A significant challenge with herpes is that many infected individuals are asymptomatic or experience mild symptoms that can be mistaken for other conditions, leading to a lack of awareness about their infection status. While there is no cure for herpes, effective management strategies exist. Prescription antiviral medications are available that can significantly reduce the frequency and severity of outbreaks and, when taken daily, can lower the risk of transmission to sexual partners.

Impact Analysis

The FDA’s primary concern is that consumers may opt for these unapproved over-the-counter products instead of seeking professional medical evaluation. This reliance on unverified remedies can lead to a dangerous delay in diagnosis and treatment. For sexually transmitted infections like herpes, delayed care can have severe consequences, including the potential for serious complications such as infertility, sepsis, and in extreme cases, death. Furthermore, individuals who believe they are being treated may unknowingly continue to spread the infection to their partners, perpetuating the public health issue. The involvement of large platforms like Amazon and Walmart amplifies this risk due to the vast reach and accessibility of their marketplaces.

“Effective treatment requires diagnosis and supervision by a licensed healthcare professional,” the FDA stated in its warning letters.

Broader Context

The availability of unapproved drugs, particularly for sensitive health conditions like herpes, underscores a persistent challenge in regulating online marketplaces. While these platforms offer convenience, they also present avenues for unverified products to reach consumers. The FDA’s action highlights the agency’s ongoing efforts to police the market for unapproved or misbranded drugs. It also serves as a reminder that homeopathic products, despite their diluted nature, are still considered drugs by the FDA and must adhere to rigorous approval processes if making therapeutic claims. The ease with which these products were purchased suggests a gap in oversight, where third-party sellers can list potentially harmful items, and fulfillment services inadvertently facilitate their distribution.

Future Outlook

Following the FDA’s warnings, Amazon and Walmart are expected to take swift action to remove the cited products from their platforms and implement stricter vetting processes for health-related items sold by third-party vendors. Failure to comply could result in significant legal and financial repercussions for the retailers. This incident may prompt increased scrutiny of online sales of all health products, potentially leading to more robust regulatory frameworks for e-commerce platforms. Consumers are strongly advised to exercise caution and always consult with healthcare providers for any health concerns, especially those related to infections, rather than relying on unproven online remedies.

Conclusion

The FDA’s intervention regarding unapproved herpes treatments sold on Amazon and Walmart is a critical step in safeguarding public health. It emphasizes the indispensable role of professional medical diagnosis and treatment for conditions like genital herpes. By alerting consumers and holding retailers accountable, the agency aims to prevent the serious health risks associated with delayed or inadequate care, reinforcing the message that genuine medical treatment should always be sought from qualified healthcare professionals.